Sensitive ASX Announcement

Argenica Receives Ethics Approval To Commence Phase 1 Trial

Published: 07/09/22, 08:11am (AEST)2 pages
Argenica Therapeutics Limited
AGN:ASXHealthcare

Recent AGN Announcements

Price Sensitive only